Bottom line
FPHAX vs FSPHX: the short answer
FPHAX (Pharmaceuticals Portfolio) and FSPHX (Health Care Portfolio) are quite different portfolios: only about 33% of their top holdings (by weight) are shared.
But FSPHX is far broader, holding 152 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.
FSPHX is cheaper at 0.62% vs 0.67% — a difference of $5.00 a year per $10,000 invested.
Over five years, FPHAX returned +12.6% a year vs +4.0% for FSPHX.
Updated Nov 19, 2026
FPHAX vs FSPHX side by side
| FPHAX | FSPHX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.67% | 0.62% |
| Annual cost per $10k | $67 | $62 |
| 10-yr cost on $10k (prospectus) | $835 | $774 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +30.3% | +14.4% |
| 5-yr return (annualized) | +12.6% | +4.0% |
| 10-yr return (annualized) | +10.0% | +9.0% |
| Best quarter | +18.5% | +22.2% |
| Worst quarter | −13.6% | −15.0% |
| Net assets (fund) | $1.5B | $5.8B |
| Number of holdings | 57 | 152 |
| Portfolio turnover | 77% | 69% |
| Returns as of | Apr 30, 2026 | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FPHAX | FSPHX | Difference |
|---|---|---|---|
| 2025 | +30.3% | +14.4% | +15.9% |
| 2024 | +9.4% | +4.9% | +4.5% |
| 2023 | +12.5% | +4.1% | +8.4% |
| 2022 | +1.0% | −12.8% | +13.8% |
| 2021 | +11.8% | +11.5% | +0.3% |
| 2020 | +11.1% | +24.4% | −13.4% |
| 2019 | +31.6% | +31.5% | +0.2% |
| 2018 | +5.8% | +7.4% | −1.6% |
| 2017 | +10.7% | +24.0% | −13.3% |
| 2016 | −16.3% | −10.7% | −5.6% |
Source: Fund prospectus bar charts
Holdings overlap
8 of FPHAX's top 25 holdings also appear in FSPHX's top 25.
| Holding | FPHAX | FSPHX |
|---|---|---|
| ELI LILLY and CO | 28.78% | 8.03% |
| Viatris Inc | 5.45% | 1.20% |
| Ucb Sa | 5.09% | 2.03% |
| MERCK and CO INC | 4.74% | 1.60% |
| Gilead Sciences Inc | 3.97% | 2.21% |
| JOHNSON and JOHNSON | 3.77% | 4.91% |
| Fidelity Revere Street Trust | 2.44% | 2.17% |
| Moderna Inc | 1.57% | 1.18% |
Source: SEC Form N-PORT
FPHAX top 10
- ELI LILLY and CO — 28.78%
- Gsk Plc — 8.17%
- Viatris Inc — 5.45%
- Ucb Sa — 5.09%
- MERCK and CO INC — 4.74%
- Roche Holding Ag — 4.54%
- Legend Biotech Corp — 4.53%
- Astrazeneca Plc — 4.22%
- Elanco Animal Health Inc — 4.15%
- Jazz Pharmaceuticals Plc — 4.09%
FSPHX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
FAQ
What is the difference between FPHAX and FSPHX?
Which is cheaper, FPHAX or FSPHX?
Should I own both FPHAX and FSPHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.